[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  @BiotechTV BiotechTV BiotechTV posts on X about $imrx, asos, nyc, $nuvb the most. They currently have XXXXX followers and XXX posts still getting attention that total XXX engagements in the last XX hours. ### Engagements: XXX [#](/creator/twitter::1655096847793377284/interactions)  - X Week XXXXXX -XX% - X Month XXXXXX -XX% - X Months XXXXXXX -XX% - X Year XXXXXXXXX -XX% ### Mentions: X [#](/creator/twitter::1655096847793377284/posts_active)  - X Week XX no change - X Month XX -XX% - X Months XXX +9.60% - X Year XXX +51% ### Followers: XXXXX [#](/creator/twitter::1655096847793377284/followers)  - X Week XXXXX +0.30% - X Month XXXXX +1.80% - X Months XXXXX +19% - X Year XXXXX +37% ### CreatorRank: XXXXXXXXX [#](/creator/twitter::1655096847793377284/influencer_rank)  ### Social Influence [#](/creator/twitter::1655096847793377284/influence) --- **Social category influence** [stocks](/list/stocks) XXXX% [fashion brands](/list/fashion-brands) XXXX% [exchanges](/list/exchanges) XXXX% [finance](/list/finance) XXXX% [cryptocurrencies](/list/cryptocurrencies) XXXX% **Social topic influence** [$imrx](/topic/$imrx) 1.75%, [asos](/topic/asos) #71, [nyc](/topic/nyc) 0.88%, [$nuvb](/topic/$nuvb) 0.88%, [$aclx](/topic/$aclx) 0.88%, [$4521t](/topic/$4521t) 0.88%, [$atxs](/topic/$atxs) 0.88%, [$4543t](/topic/$4543t) 0.88%, [$9b](/topic/$9b) 0.88%, [sanofi](/topic/sanofi) XXXX% **Top accounts mentioned or mentioned by** [@bradloncar](/creator/undefined) [@cngarabedian](/creator/undefined) [@aviadobio](/creator/undefined) [@arsenalbio](/creator/undefined) [@williamblair](/creator/undefined) [@tevausas](/creator/undefined) [@albertbourla](/creator/undefined) [@nellomainolfi](/creator/undefined) [@nyse](/creator/undefined) [@kdrazan](/creator/undefined) [@btprop](/creator/undefined) [@vintweeta](/creator/undefined) [@hcwco](/creator/undefined) [@arcellx](/creator/undefined) [@mateosagan](/creator/undefined) [@rs_flinn](/creator/undefined) [@rareagainstrfk](/creator/undefined) [@johnmeta_](/creator/undefined) [@evag6068](/creator/undefined) [@yaireinhorn](/creator/undefined) **Top assets mentioned** [Arcellx, Inc. Common Stock (ACLX)](/topic/$aclx) [Sanofi (SNY)](/topic/sanofi) [Soleno Therapeutics, Inc. Common Stock (SLNO)](/topic/$slno) [Sarepta Therapeutics, Inc. (SRPT)](/topic/$srpt) [Crinetics Pharmaceuticals, Inc. (CRNX)](/topic/$crnx) [Xenon Pharmaceuticals Inc (XENE)](/topic/$xene) [Biohaven Pharmaceutical Holding Company Ltd. (BHVN)](/topic/$bhvn) [Vertex Protocol (VRTX)](/topic/$vrtx) [Dyne Therapeutics, Inc. Common Stock (DYN)](/topic/dyne-therapeutics) ### Top Social Posts [#](/creator/twitter::1655096847793377284/posts) --- Top posts by engagements in the last XX hours ": Souffl Therapeutics exited stealth today with the goal of developing nucleic acid therapies like siRNAs & ASOs delivered to any cell in the body by targeting internalizing receptors. CEO @VCAmir talks the science. Full video:" [X Link](https://x.com/BiotechTV/status/1975546911659860198) [@BiotechTV](/creator/x/BiotechTV) 2025-10-07T13:01Z 9437 followers, 4201 engagements ": BiotechTV will be back in NYC broadcasting from the iconic @NYSE tomorrow afternoon. Please tune in. $NUVB $IMRX" [X Link](https://x.com/BiotechTV/status/1975642478750367956) [@BiotechTV](/creator/x/BiotechTV) 2025-10-07T19:20Z 9438 followers, 12.1K engagements ": Candid Therapeutics licensed a trispecific T-cell engager from WuXi Biologics today for autoimmune disease. Chairman & CEO Ken Song talks about T-cell engagers vs CAR-Ts for autoimmune. Full video:" [X Link](https://x.com/BiotechTV/status/1876437099723026768) [@BiotechTV](/creator/x/BiotechTV) 2025-01-07T01:14Z 9438 followers, 2141 engagements ": @arcellx CEO Rami Elghandour discusses the results presented today of the iMMagine-1 Study for the company's BCMA CAR-T. #EHA2025 $ACLX Full video:" [X Link](https://x.com/BiotechTV/status/1933974834691600385) [@BiotechTV](/creator/x/BiotechTV) 2025-06-14T19:48Z 9439 followers, 7285 engagements ": @AstriaTx licensed its HAE treatment Navenibart to Kaken Pharmaceutical for the Japanese market. It is a kallikrein inhibitor that is in phase X and is dosed up to every six months. $ATXS Full video:" [X Link](https://x.com/BiotechTV/status/1953537900907294759) [@BiotechTV](/creator/x/BiotechTV) 2025-08-07T19:25Z 9438 followers, 1832 engagements ": @Immuneering's CEO walks us through the company's MEK data in pancreatic cancer and explains the science behind 'deep cyclic inhibition'. $IMRX Full video:" [X Link](https://x.com/BiotechTV/status/1976140728234393745) [@BiotechTV](/creator/x/BiotechTV) 2025-10-09T04:20Z 9438 followers, 3892 engagements ": Oxford's @organ_ox became one of the UK's biggest news stories when it was announced it would be acquired by Japan's Terumo for approximately $XXX billion - here's the revolutionary technology behind it. Full video:" [X Link](https://x.com/BiotechTV/status/1976644818320392290) [@BiotechTV](/creator/x/BiotechTV) 2025-10-10T13:43Z 9438 followers, 1188 engagements ": Kate Haviland discusses the $9B+ acquisition of Blueprint by Sanofi being chair of Fulcrum her thoughts on M&A and what is interesting in biotech today. Full video:" [X Link](https://x.com/BiotechTV/status/1978242737057956218) [@BiotechTV](/creator/x/BiotechTV) 2025-10-14T23:33Z 9439 followers, 1657 engagements ": Sunrise Group which has designed a mandibular sensor for at-home diagnosis of sleep apnea recently raised $29M to expand its digital sleep clinic that patients can access remotely. Full video:" [X Link](https://x.com/BiotechTV/status/1976755484313927729) [@BiotechTV](/creator/x/BiotechTV) 2025-10-10T21:03Z 9438 followers, 1170 engagements ": @LegendBiotech's CEO Ying Huang discusses new CARVYKTI data at #ASCO25 as well as early stage data for emerging CAR-T targets against solid tumors. $LEGN Full video:" [X Link](https://x.com/BiotechTV/status/1929333024186876329) [@BiotechTV](/creator/x/BiotechTV) 2025-06-02T00:23Z 9437 followers, 6122 engagements ": R.W. Baird Managing Director & Senior Biotech Analyst @BrianSkorney discusses numerous battleground companies in biotech. $SLNO $SRPT $LXEO $ENTA $CRNX $VRTX $XENE $BHVN Full video:" [X Link](https://x.com/BiotechTV/status/1976052122505576769) [@BiotechTV](/creator/x/BiotechTV) 2025-10-08T22:28Z 9437 followers, 38K engagements ": @Dyne_tx's CSO Ron Batra describes the company's FORCE platform and previews big trial readouts scheduled in DMD and DM1 over the next year. $DYN Full video:" [X Link](https://x.com/BiotechTV/status/1978133252591280386) [@BiotechTV](/creator/x/BiotechTV) 2025-10-14T16:18Z 9437 followers, 1349 engagements ": @benchlings Head of Product - Applications Derek Halliday describes how technology is changing the Development side of R&D and how Benchling has helped Merck modernize its bioanalytical systems in this regard. #sponsored" [X Link](https://x.com/BiotechTV/status/1978206872931803549) [@BiotechTV](/creator/x/BiotechTV) 2025-10-14T21:10Z 9437 followers, 1531 engagements ": This week @Regeneron published data in @NEJM showing that its gene therapy improved hearing and speech perception in XX of XX children with a genetic form of hearing loss. @chloeckirk breaks it down. Link to research:" [X Link](https://x.com/BiotechTV/status/1979295979456118902) [@BiotechTV](/creator/x/BiotechTV) 2025-10-17T21:18Z 9437 followers, 3749 engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@BiotechTV BiotechTV
BiotechTV posts on X about $imrx, asos, nyc, $nuvb the most. They currently have XXXXX followers and XXX posts still getting attention that total XXX engagements in the last XX hours.
Engagements: XXX #
- X Week XXXXXX -XX%
- X Month XXXXXX -XX%
- X Months XXXXXXX -XX%
- X Year XXXXXXXXX -XX%
Mentions: X #
- X Week XX no change
- X Month XX -XX%
- X Months XXX +9.60%
- X Year XXX +51%
Followers: XXXXX #
- X Week XXXXX +0.30%
- X Month XXXXX +1.80%
- X Months XXXXX +19%
- X Year XXXXX +37%
CreatorRank: XXXXXXXXX #
Social Influence #
Social category influence stocks XXXX% fashion brands XXXX% exchanges XXXX% finance XXXX% cryptocurrencies XXXX%
Social topic influence $imrx 1.75%, asos #71, nyc 0.88%, $nuvb 0.88%, $aclx 0.88%, $4521t 0.88%, $atxs 0.88%, $4543t 0.88%, $9b 0.88%, sanofi XXXX%
Top accounts mentioned or mentioned by @bradloncar @cngarabedian @aviadobio @arsenalbio @williamblair @tevausas @albertbourla @nellomainolfi @nyse @kdrazan @btprop @vintweeta @hcwco @arcellx @mateosagan @rs_flinn @rareagainstrfk @johnmeta_ @evag6068 @yaireinhorn
Top assets mentioned Arcellx, Inc. Common Stock (ACLX) Sanofi (SNY) Soleno Therapeutics, Inc. Common Stock (SLNO) Sarepta Therapeutics, Inc. (SRPT) Crinetics Pharmaceuticals, Inc. (CRNX) Xenon Pharmaceuticals Inc (XENE) Biohaven Pharmaceutical Holding Company Ltd. (BHVN) Vertex Protocol (VRTX) Dyne Therapeutics, Inc. Common Stock (DYN)
Top Social Posts #
Top posts by engagements in the last XX hours
": Souffl Therapeutics exited stealth today with the goal of developing nucleic acid therapies like siRNAs & ASOs delivered to any cell in the body by targeting internalizing receptors. CEO @VCAmir talks the science. Full video:"
X Link @BiotechTV 2025-10-07T13:01Z 9437 followers, 4201 engagements
": BiotechTV will be back in NYC broadcasting from the iconic @NYSE tomorrow afternoon. Please tune in. $NUVB $IMRX"
X Link @BiotechTV 2025-10-07T19:20Z 9438 followers, 12.1K engagements
": Candid Therapeutics licensed a trispecific T-cell engager from WuXi Biologics today for autoimmune disease. Chairman & CEO Ken Song talks about T-cell engagers vs CAR-Ts for autoimmune. Full video:"
X Link @BiotechTV 2025-01-07T01:14Z 9438 followers, 2141 engagements
": @arcellx CEO Rami Elghandour discusses the results presented today of the iMMagine-1 Study for the company's BCMA CAR-T. #EHA2025 $ACLX Full video:"
X Link @BiotechTV 2025-06-14T19:48Z 9439 followers, 7285 engagements
": @AstriaTx licensed its HAE treatment Navenibart to Kaken Pharmaceutical for the Japanese market. It is a kallikrein inhibitor that is in phase X and is dosed up to every six months. $ATXS Full video:"
X Link @BiotechTV 2025-08-07T19:25Z 9438 followers, 1832 engagements
": @Immuneering's CEO walks us through the company's MEK data in pancreatic cancer and explains the science behind 'deep cyclic inhibition'. $IMRX Full video:"
X Link @BiotechTV 2025-10-09T04:20Z 9438 followers, 3892 engagements
": Oxford's @organ_ox became one of the UK's biggest news stories when it was announced it would be acquired by Japan's Terumo for approximately $XXX billion - here's the revolutionary technology behind it. Full video:"
X Link @BiotechTV 2025-10-10T13:43Z 9438 followers, 1188 engagements
": Kate Haviland discusses the $9B+ acquisition of Blueprint by Sanofi being chair of Fulcrum her thoughts on M&A and what is interesting in biotech today. Full video:"
X Link @BiotechTV 2025-10-14T23:33Z 9439 followers, 1657 engagements
": Sunrise Group which has designed a mandibular sensor for at-home diagnosis of sleep apnea recently raised $29M to expand its digital sleep clinic that patients can access remotely. Full video:"
X Link @BiotechTV 2025-10-10T21:03Z 9438 followers, 1170 engagements
": @LegendBiotech's CEO Ying Huang discusses new CARVYKTI data at #ASCO25 as well as early stage data for emerging CAR-T targets against solid tumors. $LEGN Full video:"
X Link @BiotechTV 2025-06-02T00:23Z 9437 followers, 6122 engagements
": R.W. Baird Managing Director & Senior Biotech Analyst @BrianSkorney discusses numerous battleground companies in biotech. $SLNO $SRPT $LXEO $ENTA $CRNX $VRTX $XENE $BHVN Full video:"
X Link @BiotechTV 2025-10-08T22:28Z 9437 followers, 38K engagements
": @Dyne_tx's CSO Ron Batra describes the company's FORCE platform and previews big trial readouts scheduled in DMD and DM1 over the next year. $DYN Full video:"
X Link @BiotechTV 2025-10-14T16:18Z 9437 followers, 1349 engagements
": @benchlings Head of Product - Applications Derek Halliday describes how technology is changing the Development side of R&D and how Benchling has helped Merck modernize its bioanalytical systems in this regard. #sponsored"
X Link @BiotechTV 2025-10-14T21:10Z 9437 followers, 1531 engagements
": This week @Regeneron published data in @NEJM showing that its gene therapy improved hearing and speech perception in XX of XX children with a genetic form of hearing loss. @chloeckirk breaks it down. Link to research:"
X Link @BiotechTV 2025-10-17T21:18Z 9437 followers, 3749 engagements